ABEO
Abeona Therapeutics Inc
5.40$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +382.8% | +38.7% | +61.0% | -2.4% | +28.1% | -32.3% | -47.4% | -19.3% | -0.3% | +70.2% | +101.6% | |
| – | +251.1% | +71.1% | +102.5% | -36.8% | +49.0% | -26.2% | -42.4% | -5.7% | +5.0% | +80.9% | +103.2% | |
| – | +248.4% | +72.3% | +99.2% | -86.4% | +589.4% | -90.3% | +161.5% | -56.8% | +1.8% | +61.4% | +235.8% | |
| – | +248.4% | +72.3% | +99.2% | -38.3% | +52.1% | -26.5% | -52.6% | +15.8% | +0.1% | +87.1% | +95.9% | |
| – | +228.6% | +7.8% | -13.7% | -24.3% | -100.0% | – | – | -93.7% | +1,200.0% | -32.4% | +306.5% | |
| – | – | -100.0% | – | – | – | – | – | +33,799,900.0% | – | – | – | |
| – | +8,650.0% | +106.0% | +90.6% | +587.3% | +39.3% | +39.5% | +18.5% | -49.1% | – | – | – | |
| – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | – | |
| – | +32.4% | +26.9% | -52.6% | +982.3% | -15.9% | -95.9% | -7.7% | – | – | – | – | |
| – | +4.8% | -3.0% | -27.5% | +365.6% | +11.4% | +8.2% | -23.5% | +0.6% | +31.3% | +32.0% | -7.0% | |
| – | -49.0% | +461.7% | -32.4% | +263.0% | +90.1% | +8.4% | -60.4% | -53.2% | +72.5% | +23.6% | +78.3% | |
| – | -250.5% | – | – | – | -83.0% | +20.2% | -11.0% | -2.5% | -43.7% | +576.3% | +93.9% | |
| – | -53.9% | +322.2% | -49.1% | +225.5% | -38.5% | +24.8% | -7.9% | -58.1% | +2.6% | +85.2% | +129.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -40.1% | |
| – | +1,306.2% | +46.3% | +71.6% | -21.2% | +33.1% | -42.5% | -58.7% | -36.8% | -44.6% | +197.0% | +261.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5,582.2% | +23.8% | +21.8% | +14.2% | +5.9% | +84.1% | +6.2% | +99.6% | +171.9% | +92.0% | +61.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.